98 related articles for article (PubMed ID: 12587041)
1. [Influence of ion pump-inhibiting drugs on the accumulation of ofloxacin and grepafloxacin in human polymorphonuclear leukocytes].
Orero A; Cantón E; Pemán J; Velert MM; Bermejo MV
Rev Esp Quimioter; 2002 Dec; 15(4):352-9. PubMed ID: 12587041
[TBL] [Abstract][Full Text] [Related]
2. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
Yamaguchi H; Yano I; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
[TBL] [Abstract][Full Text] [Related]
3. [Effect of antiinflammatory agents on the accumulation of ofloxacin in human polymorphonuclear leukocytes].
Orero A; Cantón E; Bermejo MV; Velert MM; Cabrera E; Pemán J; Gobernado M
Rev Esp Quimioter; 1999 Jun; 12(2):144-8. PubMed ID: 10562676
[TBL] [Abstract][Full Text] [Related]
4. [Uptake of 5 fluoroquinolones into human polymorphonuclear cells].
Ballesta S; Pascual A; García I; Perea EJ
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):470-3. PubMed ID: 9011203
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes.
Taira K; Koga H; Kohno S
Antimicrob Agents Chemother; 1993 Sep; 37(9):1877-81. PubMed ID: 8239600
[TBL] [Abstract][Full Text] [Related]
6. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.
Ito T; Yano I; Masuda S; Hashimoto Y; Inui K
Pharm Res; 1999 Apr; 16(4):534-9. PubMed ID: 10227708
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
[TBL] [Abstract][Full Text] [Related]
8. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
Perea EJ; García I; Pascual A
Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
Mattina R; Bellotti M; Raimondi A; Sander K
Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
Yamaguchi H; Yano I; Saito H; Inui K
J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
Shakibaei M; Baumann-Wilschke I; Rücker M; Stahlmann R
Arch Toxicol; 2002 Jan; 75(11-12):725-33. PubMed ID: 11876506
[TBL] [Abstract][Full Text] [Related]
12. Carrier-mediated uptake of Levofloxacin by BeWo cells, a human trophoblast cell line.
Polachek H; Holcberg G; Polachek J; Rubin M; Feinshtein V; Sheiner E; Ben-Zvi Z
Arch Gynecol Obstet; 2010 May; 281(5):833-8. PubMed ID: 19629508
[TBL] [Abstract][Full Text] [Related]
13. Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes.
Ozaki M; Komori K; Matsuda M; Yamaguchi R; Honmura T; Tomii Y; Nishimura I; Nishino T
Antimicrob Agents Chemother; 1996 Mar; 40(3):739-42. PubMed ID: 8851603
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
Coban AY; Birinci A; Ekinci B; Durupinar B
Mikrobiyol Bul; 2004; 38(1-2):21-5. PubMed ID: 15293898
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of grepafloxacin.
Efthymiopoulos C
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
[TBL] [Abstract][Full Text] [Related]
16. The comparative arthropathy of fluoroquinolones in dogs.
Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
[TBL] [Abstract][Full Text] [Related]
17. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.
Michot JM; Seral C; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2005 Jun; 49(6):2429-37. PubMed ID: 15917543
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K
Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367
[TBL] [Abstract][Full Text] [Related]
19. [Grepafloxacin (Raxar)].
Friis HM
Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
[No Abstract] [Full Text] [Related]
20. Differential uptake of grepafloxacin by human circulating blood neutrophils and those exudated into tissues.
Niwa M; Hotta K; Kanamori Y; Matsuno H; Kozawa O; Hirota M; Uematsu T
Eur J Pharmacol; 2001 Sep; 428(1):121-6. PubMed ID: 11779028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
